Well we got the big news a few days ago and Stoney missed it!>
IMPAX Files Revised Submission with Office of the Chief Accountant of the SEC
- BusinessWire
HAYWARD, Calif., Feb 02, 2007 (BUSINESS WIRE) -- IMPAX Laboratories, Inc. today announced that the Company has filed a revised submission with the Office of the Chief Accountant (OCA) of the Securities and Exchange Commission (SEC), seeking the OCA's concurrence in its proposed revised revenue-recognition policy relating to transactions under the Company's Strategic Alliance Agreement with an affiliate of Teva Pharmaceutical Industries, Ltd. (Teva).
The submission is the culmination of an analysis of the appropriate accounting under the agreement with Teva that has taken nearly two years to complete. The content of the submission will remain confidential until the Company receives a response from the OCA. The proposed new methodology will not have an impact on the Company's cash position or liquidity.
Arthur A. Koch, senior vice president and chief financial officer, said, "This submission is a critical step for IMPAX Laboratories towards completion of the audits of its 2004, 2005 and 2006 financial statements and bringing its SEC filings current. We estimate that we will achieve this within eight to 12 weeks after a favorable determination by the OCA."
The stock ran to $10.70 and has pulled in to $10.50.
Now the countdown begins... will IPXL get re listed?
Will the stock soar to $14? Will the accounting method get the thumbs down from the SEC and will the whole investing thesis in this name go out the window along with my retirement?